You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Results of screening studies for long-term iVDPV excretion among individuals with PIDs

From: Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs

Country Total patients with PIDs studied CVID patients studied Poliovirus excretors iVDPV excretors Patients with > 6 months of documented excretion Source(s)
Bangladesh 13 0 1 0 0 [52]
Brazil 95 70 3 0 0 [16]
China 167 22 3 0 0 [52]
Egypta 15 3 2 0 0 [21]
Iran 43 16 1 0 0 [52]
Italy 38 0 0 0 0 [17]
Mexico 33 5 1 0 0 [16]
Philippines 70 6 1 0 0 [52, 60]
Russia 136 27 0 0 0 [52]
Sri Lanka 51 13 5 2 1b [20, 52]
Tunisia 16 2 4 0 0 [61]
Tunisia 82 14 6   0 [19, 52]
United Kingdom 125 65 0 0 0 [16]
United States 94 75 0 0 0 [16]
Total 978 318 27 2 1  
  1. aPreliminary results
  2. bThe prolonged iVDPV excretor was diagnosed a CVID patient